InsiderTrades

Form 4 for GNTX GENTEX CORP

Accepted 2023-02-02 00:00:00 ET · period of report 2023-02-01 · accession 0001562180-23-000792 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-02-02 2023-02-01 GNTX Nash Kevin C CFO M - OptEx $14.70 +6,776 28.5K +31% +$99.6K
D 2023-02-02 2023-02-01 GNTX Nash Kevin C CFO S - Sale+OE $29.42 -6,776 22.6K -23% -$199.3K
D 2023-02-02 2023-02-01 GNTX Nash Kevin C CFO M - OptEx $0.00 -6,776 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-01 M A 6,776 $14.70 28,508 D — —
2 Common Common Stock 2023-02-01 S D 6,776 $29.42 22,597 D — — (F1) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. (F2) This transaction was executed in multiple trades at prices ranging from $29.32 to $29.56. The price reported above reflects the weighted average price. (F3) Column 5 reflects the acquisition of 865 shares under the Gentex Corp. Employee Stock Purchase Plan.
3 Derivative Employee Stock Option (Right to buy) 2023-02-01 M D 6,776 $0.00 0 D $14.70 · 2017-02-22 to 2023-02-22 6,776 Common Stock (F4) These shares become exercisable as to 20% one year after date of grant and an additional 20% at each ensuing anniversary date.